Overview

A Trial of Varenicline for E-cigarette Cessation

Status:
RECRUITING

Trial end date:
2029-01-01

Target enrollment:

Participant gender:

Summary

This is randomized, placebo-controlled clinical trial in treatment-seeking adults who report regular e-cigarette use to test the hypothesis that varenicline is efficacious for quitting e-cigarettes.

Phase:

PHASE2

Details

Lead Sponsor:

Yale University

Collaborator:

National Cancer Institute (NCI)

Treatments:

BID protein, human
Varenicline